World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
48
Citations
52471
World Ranking
18161
National Ranking
1248

Overview

Emmanuelle Charpentier is affiliated with the Max Planck Institute for Infection Biology in Germany. Their research primarily focuses on Biochemistry, Genetics, and Molecular Biology, with a particular emphasis on Molecular Biology, Genetics, Public Health, Environmental and Occupational Health, Ecology, and Endocrinology.

The scientist's work covers a range of topics including:

  • RNA and protein synthesis mechanisms
  • Bacterial Genetics and Biotechnology
  • CRISPR and Genetic Engineering
  • Bacteriophages and microbial interactions
  • RNA modifications and cancer
  • Streptococcal Infections and Treatments
  • Genomics and Phylogenetic Studies

Some recent papers authored or co-authored by Emmanuelle Charpentier include:

  • Distinct Polysaccharide Utilization Determines Interspecies Competition between Intestinal Prevotella spp., 2020, Cell Host & Microbe
  • Bridge helix arginines play a critical role in Cas9 sensitivity to mismatches, 2020, Nature Chemical Biology
  • An RNA-seq based comparative approach reveals the transcriptome-wide interplay between 3'-to-5' exoRNases and RNase Y, 2020, Nature Communications
  • Survival Strategies of Streptococcus pyogenes in Response to Phage Infection, 2021, Viruses
  • The energy metabolism of Cupriavidus necator in different trophic conditions, 2024, Applied and Environmental Microbiology

The frequent co-authors listed for Emmanuelle Charpentier are:

  • Rina Ahmed-Begrich
  • Marc Erhardt
  • Karin Hahnke
  • Thibaud T. Renault
  • Katja Schmidt

Emmanuelle Charpentier's research is often published in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • mSystems
  • Cell Host & Microbe
  • Nature Chemical Biology

Best Publications

  • A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

    Martin Jinek;Krzysztof Chylinski;Krzysztof Chylinski;Ines Fonfara;Michael Hauer

  • The new frontier of genome engineering with CRISPR-Cas9

    Jennifer A. Doudna;Jennifer A. Doudna;Emmanuelle Charpentier;Emmanuelle Charpentier

  • CRISPR RNA maturation by trans -encoded small RNA and host factor RNase III

    Elitza Deltcheva;Krzysztof Chylinski;Krzysztof Chylinski;Cynthia M. Sharma;Karine Gonzales

  • Evolution and classification of the CRISPR-Cas systems

    Kira S. Makarova;Daniel H. Haft;Rodolphe Barrangou;Stan J. J. Brouns

  • An updated evolutionary classification of CRISPR–Cas systems

    Kira S. Makarova;Yuri I. Wolf;Omer S. Alkhnbashi;Fabrizio Costa

  • Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.

    Kira S. Makarova;Yuri I. Wolf;Jaime Iranzo;Sergey A. Shmakov

  • Structures of Cas9 Endonucleases Reveal RNA- Mediated Conformational Activation

    Martin Jinek;Fuguo Jiang;David W. Taylor;David W. Taylor;Samuel H. Sternberg

  • The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA

    Ines Fonfara;Hagen Richter;Majda Bratovič;Anaïs Le Rhun

  • The Biology of CRISPR-Cas: Backward and Forward.

    Frank Hille;Frank Hille;Hagen Richter;Shi Pey Wong;Shi Pey Wong;Shi Pey Wong;Majda Bratovič;Majda Bratovič

  • The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems

    Krzysztof Chylinski;Anaïs Le Rhun;Emmanuelle Charpentier

  • Classification and evolution of type II CRISPR-Cas systems

    Krzysztof Chylinski;Kira S. Makarova;Emmanuelle Charpentier;Eugene V. Koonin

  • Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems

    Ines Fonfara;Anaïs Le Rhun;Krzysztof Chylinski;Kira S. Makarova

  • Adopt a moratorium on heritable genome editing

    Eric S. Lander;Françoise Baylis;Feng Zhang;Emmanuelle Charpentier

  • CRISPR-Cas: biology, mechanisms and relevance

    Frank Hille;Emmanuelle Charpentier

  • Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.

    Emmanuelle Charpentier;Emmanuelle Charpentier;Hagen Richter;John van der Oost;Malcolm F. White

  • Memory of viral infections by CRISPR-Cas adaptive immune systems: Acquisition of new information

    Peter C. Fineran;Emmanuelle Charpentier

  • Biotechnology: Rewriting a genome

    Emmanuelle Charpentier;Jennifer A. Doudna

  • Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.

    Maurice Labuhn;Felix F. Adams;Michelle Ng;Sabine Knoess

  • Adaptation in CRISPR-Cas Systems

    Samuel H. Sternberg;Hagen Richter;Emmanuelle Charpentier;Udi Qimron

  • Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?

    James Anthony Tsatsaronis;James Anthony Tsatsaronis;Sandra Franch-Arroyo;Ulrike Resch;Emmanuelle Charpentier;Emmanuelle Charpentier;Emmanuelle Charpentier

Frequent Co-Authors

Jennifer A. Doudna
Jennifer A. Doudna University of California, Berkeley
Martin Jinek
Martin Jinek University of Zurich
Wendell A. Lim
Wendell A. Lim University of California, San Francisco
Lei S. Qi
Lei S. Qi Stanford University
Eugene V. Koonin
Eugene V. Koonin National Institutes of Health
Kira S. Makarova
Kira S. Makarova National Institutes of Health
Alexander F. Yakunin
Alexander F. Yakunin Bangor University
Keiichi Namba
Keiichi Namba Osaka University
Heribert Hirt
Heribert Hirt King Abdullah University of Science and Technology
John van der Oost
John van der Oost Wageningen University & Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Emmanuelle Charpentier

Trending Scientists